Roche Holding AG

CH

ROG

Health Care

30.91 ₽

Current price

Buy
30.91 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    516 / 1328

  • Position in country

    206 / 449

  • Return on Assets, %

    14.2

    -2.7

  • Net income margin, %

    16.5

    2.8

  • EBITDA margin, %

    33.4

    10.8

  • Debt to Equity, %

    99.6

    19.2

  • Intangible assets and goodwill, %

    26.7

    3.6

  • Revenue CAGR 3Y, %

    0.2

    8.5

  • Revenue Y, % chg

    0.4

    0.5

  • P/E

    15.6

    22.7

  • P/BV

    6

    1.5

  • P/S

    3

    2.3

  • EV/S

    3.5

    2.4

  • EV/EBITDA

    9.4

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    25.3

    51.3

  • Forward P/E

    11.4

    15.6

  • Dividend Yield, %

    4.4

    1.7

  • Forward Dividend Yield, %

    4.5

    0.2

  • Expected dividend per share

    1.3

    0

  • Payout Ratio, %

    67.5

    30.3

  • Dividend Ex Date

    2024-03-14

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • Vifor Pharma AG

    00%

  • AstraZeneca PLC

    00%

  • Eli Lilly and Co

    00%

  • Roche Holding AG

    00%

  • Dottikon Es Holding AG

    00%

  • Novartis AG

    00%

  • Sandoz Group AG

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Switzerland

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    201974

  • Ticker

    RHHBY.PK

  • ISIN

    US7711951043

  • IPO date

    2001-05-04

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-01

  • Date fact. publication of reports

    2023-12-31

Company Description

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: